← Back to all trials
Recruiting
NCT06924359
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
Conditions: Alzheimer's Disease (AD)
Sex: All
Ages: 50 Years – N/A
Enrollment: 200
Sponsor: Peking University First Hospital
Location: Peking University First Hospital Beijing
Summary
With the accelerating global aging population, dementia has become a pressing worldwide issue. This project aims to identify specific plasma biomarkers and ocular indicators for the early detection of Alzheimer's disease (AD).
Eligibility Criteria
Inclusion Criteria:
* Male or female participants aged ≥ 50 years;
* Participants diagnosed with Alzheimer's Disease (AD), mild cognitive decline (MCI), subjective cognitive decline (SCD), or cognitively normal (CN);
* Signed informed consent form
Exclusion Criteria:
* Presence of other neurological disorders and systemic diseases that may cause cognitive impairment;
* Inability to cooperate with cognitive assessments;
* Refusal to undergo blood sampling.
Source: ClinicalTrials.gov (NCT06924359). StuddyBuddy aggregates publicly available trial information.
